Histidine-rich glycoprotein inhibits HIV-1 infection in a pH-dependent manner

DANTAS, EZEQUIEL; DÍAZ, FERNANDO ERRA; GERBER, PEHUÉN PEREYRA; VARESE, AUGUSTO; JERUSALINSKY, DIANA ALICIA; EPSTEIN, ALBERTO L.; GARCÍA RIVELLO, HERNÁN J.; DEL VALLE JAÉN, ANA; PANDOLFI, JULIETA B.; CEBALLOS, ANA; OSTROWSKI, MATIAS; SABATTÉ*, JUAN (IGUAL CONTRIBUCIÓN); GEFFNER*, JORGE (IGUAL CONTRIBUCIÓN)

JOURNAL OF VIROLOGY

AMER SOC MICROBIOLOGY

Año: 2019 vol. 93

0022-538X

Histidine-rich glycoprotein (HRG) is an abundant plasma protein with a multidomain structure, allowing its interaction with many ligands, including phospholipids, plasminogen, fibrinogen, IgG antibodies, and heparan sulfate. HRG has been shown to regulate different biological responses, such as angiogenesis, coagulation, and fibrinolysis. Here, we found that HRG almost completely abrogated the infection of Ghost cells, Jurkat cells, CD4 T cells, and macrophages by HIV-1 at a low pH (range, 6.5 to 5.5) but not at a neutral pH. HRG was shown to interact with the heparan sulfate expressed by target cells, inhibiting an early postbinding step associated with HIV-1 infection. More importantly, by acting on the viral particle itself, HRG induced a deleterious effect, which reduces viral infectivity. Because cervicovaginal secretions in healthy women show low pH values, even after semen deposition, our observations suggest that HRG might represent a constitutive defense mechanism in the vaginal mucosa. Of note, low pH also enabled HRG to inhibit the infection of HEp-2 cells and Vero cells by respiratory syncytial virus (RSV) and herpes simplex virus 2 (HSV-2), respectively, suggesting that HRG might display broad antiviral activity under acidic conditions.